Search research articles
Contact Us
Filters
Showing results (1-10 of 170) with videos related to
Page
of 17
Sort By:
JAMA Network Open
|
September 14, 2021
Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients-Room for Improvement and Much to Learn
Joshua A Hill
Current Opinion in Infectious Diseases
|
October 1, 2019
Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies
Joshua A Hill
Handbook of Clinical Neurology
|
July 13, 2014
Human herpesvirus 6 and the nervous system
Joshua A Hill, Nagagopal Venna
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 1, 2020
To Toci or Not to Toci for Coronavirus Disease 2019 (COVID-19): Is That Still the Question?
Guang-Shing Cheng, Joshua A Hill
Current Opinion in Virology
|
October 7, 2014
Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials
Joshua A Hill, Danielle M Zerr
Blood
|
June 26, 2020
How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
Joshua A Hill, Susan K Seo
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 28, 2023
COVID-19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)-T-cell therapy
Eleftheria Kampouri, Joshua A Hill, Veronica Dioverti
Viruses
|
April 27, 2024
Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape
Eleftheria Kampouri, Guy Handley, Joshua A Hill
Current Opinion in Infectious Diseases
|
October 3, 2020
Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties
Ghady Haidar, Will Garner, Joshua A Hill
Transplantation and Cellular Therapy
|
August 5, 2023
Letter to the Editor Regarding "Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation"
Guy Handley, Yanina Pasikhova, Joshua A Hill
Page
of 17
Search research articles
Search
Showing results (1-10 of 170) with videos related to
Sort By:
Page
of 17
JAMA Network Open
|
September 14, 2021
Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients-Room for Improvement and Much to Learn
Joshua A Hill
Current Opinion in Infectious Diseases
|
October 1, 2019
Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies
Joshua A Hill
Handbook of Clinical Neurology
|
July 13, 2014
Human herpesvirus 6 and the nervous system
Joshua A Hill, Nagagopal Venna
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 1, 2020
To Toci or Not to Toci for Coronavirus Disease 2019 (COVID-19): Is That Still the Question?
Guang-Shing Cheng, Joshua A Hill
Current Opinion in Virology
|
October 7, 2014
Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials
Joshua A Hill, Danielle M Zerr
Blood
|
June 26, 2020
How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
Joshua A Hill, Susan K Seo
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 28, 2023
COVID-19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)-T-cell therapy
Eleftheria Kampouri, Joshua A Hill, Veronica Dioverti
Viruses
|
April 27, 2024
Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape
Eleftheria Kampouri, Guy Handley, Joshua A Hill
Current Opinion in Infectious Diseases
|
October 3, 2020
Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties
Ghady Haidar, Will Garner, Joshua A Hill
Transplantation and Cellular Therapy
|
August 5, 2023
Letter to the Editor Regarding "Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation"
Guy Handley, Yanina Pasikhova, Joshua A Hill
Page
of 17